Regulations.gov document
Interim Response Letter from FDA CDER to Valisure, LLC
Other · FDA-2021-P-0338 · posted Sep 20, 2021
Key facts
| Document ID | FDA-2021-P-0338-0018 |
|---|---|
| Title | Interim Response Letter from FDA CDER to Valisure, LLC |
| Document type | Other |
| Subtype | Response(s) |
| Agency | FDA |
| Docket | FDA-2021-P-0338 |
| Posted | Sep 20, 2021 |
| Comment period opens | Sep 20, 2021 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: